Georgia's Online Cancer Information Center

The Prostate Cancer Foundation's Covid-19 Resources

Prostate Cancer Foundation

At PCF, we realize that many of you who have been affected by prostate cancer, or whose loved ones have been affected by prostate cancer, might be wondering if special precautions need to be taken with the coronavirus pandemic unfolding. We have always believed that evidence out of science and research are the best tools for solving patients’ problems, whether that’s cancer or public health emergencies. As such, we will do our best to use science to provide information and a steady hand in this tumultuous situation.

Scientists know that the coronavirus (aka COVID-19 COrona VIrus Disease 2019) can affect your immune system, although we are still learning more. Based on recent data as reported in the journal The Lancet, it appears that the virus hits the immune system early and knocks down the white blood cells that fight infections. This translates to respiratory disease for most patients who become sick with COVID-19.

The most important thing to remember, whether you have been affected by prostate cancer or not, is that if you are having symptoms as described here, such as a fever (99.1°F [37.3°C] or higher), persistent cough, or shortness of breath, you need to call your doctor.

If you are not having symptoms, it is important that you follow the guidelines to stay safe and avoid spreading the disease. It is critical that all citizens, not just those with prostate cancer, adhere to CDC and local public health guidelines (here’s an example of one source of local guidelines from the County of Los Angeles). You can view the full, trusted list of prevention tactics here, but our top three are: 1) wash your hands for 20 seconds with soap, especially after blowing your nose and before eating, 2) stay 6 feet away from people if you are out in public, and 3) keep your hands away from your face, where the virus can readily enter through your eyes, nose, and mouth.

That said, here are a few extra details for those of you in the prostate cancer journey:

  • If you have been diagnosed with early-stage prostate cancer — for example, you’re on active surveillance, are receiving radiation treatment, or are scheduled for surgery — you are not at increased risk of severe disease with COVID-19. This is because early prostate cancer has not been shown to significantly affect your immune system and your ability to fight infection. Unlike some blood cancers, early prostate cancer does not affect your T cells’ and B cells’ (i.e., the cells that rule your immune system) ability to fight viral and bacterial infections normally.
  • If you’re on a form of hormone therapy, there is no published evidence of increased risk of severity of Coronavirus infection. Extensive research in tens of thousands of patients on medications such as Lupron® or Zytiga® or Xtandi® shows there is no evidence that these treatments put a prostate cancer patient at higher risk of other viral infections like seasonal influenza, the common cold, or hepatitis. Experts feel the immune cells are normally functioning in normal virus infections in men on hormonal therapy for prostate cancer. Coronavirus however is not a normal virus, and if there is new data on patients on hormonal therapy with COVID-19 we are monitoring it and will share it.
  • Chemotherapy treatment (such as taxotere, carboplatin, or cabazitaxel) for advanced prostate cancer could increase your risk of greater Coronavirus infection severity. PCF and the American Society of Clinical Oncology (ASCO) and the CDC are monitoring the data on the treatment and outcomes of cancer patients with COVID-19. Because prostate cancer chemotherapy affects rapidly-dividing cells in the body — both cancerous and normal cells — your bone marrow makes fewer infection-fighting cells, leaving you at higher risk for all types of infection. You should talk to your doctor about how your particular case should be managed in your local area. If your white blood cell count is being monitored in particular during your treatment with chemotherapy, talk to your doctor before coming in for a clinic visit. You want to be assured that from getting out of your car to getting back into your car to go home, you are in a healthcare environment that is maximally prepared to reduce the spread of COVID-19 to cancer patients receiving chemotherapy.
  • Regarding the impact of COVID-19 on prostate cancer survivors, there is no data yet from China (the country where the disease has impacted the most people, and therefore where information is “leading”), but as we get it, we will share it with our community.
  • Other co-existing medical conditions can increase your risk of severe disease if you are exposed to COVID-19, regardless of prostate cancer diagnosis. These include high blood pressure, diabetes, and heart disease. Respiratory conditions (e.g., asthma, emphysema, or former heavy smoking) and conditions that affect your immune system (e.g., inflammatory bowel disease or a history of transplant) may also increase your risk.

At PCF we are tracking any real-time data on COVID-19 in cancer patients that’s credible and peer-reviewed.  This page will list a number of resources for patients and families and we will continue to update this page as more information becomes available.

With kind regards for the health of you and your family,Jonathan W. Simons, MDPresident and CEOProstate Cancer Foundation


  • The Centers for Disease Control and Prevention (CDC) website has a specific page devoted to COVID-19, including practical tips for preventing illness, updates on the number of cases in the US, and answers to commonly asked questions. People at higher risk of serious illness from the virus (defined as older adults or those with serious chronic medical conditions) should read this page carefully.
  • Johns Hopkins University’s Coronavirus Resource Center includes an update on global cases, information on transmission and diagnosis, how to protect yourself, and much more.
  • Your state or local health department website may have updated information for your specific area; larger communities may be more likely to have more comprehensive information and/or resources in multiple languages. See, for example, the County of Los Angeles Public Health website.
  • The Fred Hutchinson Cancer Research Center in Seattle has a page specifically for cancer patients, caregivers, and family members, including information about risk factors and ways to reduce your risk of infection.
View More

Media, News & Events

2021 Atlanta Precision Oncology Symposium

This one-day continuing education program will focus on current approaches to integrating and applying precision medicine into managing patients with breast, lung and genitourinary malignancies.


 Media & Events

Georgia Tech’s Durham picked to lead cancer organization

Lynn Durham has been named the new president and CEO of Georgia CORE. Durham, currently Georgia Tech vice president for institute relations, will replace Nancy Paris, who has led Georgia CORE since its inception and is retiring.



Lung Cancer Screening During the COVID-19 Pandemic

GASCO encourages all our members and members of the survivorship community to view the new video produced by the Medical Association of Georgia as the November offering of their "Top Docs" program.


 Screening & Genetics

Nancy Paris elevates cancer treatment and research in Georgia

Nancy Paris has served as president and CEO of Georgia CORE since its creation in 2005. At the end of the year, she will be retiring after spending her entire career in healthcare, during which she focused on addressing community health issues including homelessness, HIV/AIDS and rural health.


How the Georgia Sewers came to the rescue

Nearly 400 volunteers in 58 counties have been cutting out fabric and elastic, handling administrative duties and of course, sewing.


Georgia CORE and partners win five-year grant for colorectal cancer prevention

The CDC-funded program will bring colorectal screening, navigation and colonoscopies to 15,000 people in southeast and southwest Georgia.


Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.